European Drug Regulator Puts Limits on Ex-Director

Publication date: 
Monday, March 21, 2011
Jeanne Whalen
Media title: 

Europe's main drug regulator, the European Medicines Agency, said it is setting new limits on the business activities of its former executive director, Thomas Lonngren, after European legislators and transparency groups (among which ALTER-EU) complained that his health-care consulting activities presented possible conflicts of interest.


A group of nonprofit organizations advocating transparency and corporate ethics also wrote the European Commission on Feb. 24 to complain about the potential for conflicts of interest. See the attachment for the press release that ALTER-EU sent out together with its members Health Action International and the International Society for Drug Bulletins.


Snapshot original article (pdf):